Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma

计划入组 40 人 · 首次发布于 2024 年 1 月 5 日

PULSAR Radiotherapy Plus Anti-PD-1 Therapy in Metastatic Abdominopelvic Tumors

计划入组 103 人 · 首次发布于 2026 年 2 月 3 日

Depletion of Myeloid Derived Suppressor Cells to Enhance Anti PD-1 Therapy

计划入组 3 人 · 首次发布于 2017 年 10 月 5 日

Anti-CD73/PD-1 Therapy(Cidara Therapeutics Inc)

PD1-TIL

PD-L1 checkpoint inhibitor gene therapy (Affimer/gtGTU vector) (Avacta/FIT Biotech)

PD-RX Pharmaceuticals, Inc.

United States

NHI-1

United States

METABOLIC THERAPY, INC.

United States

Golidocitinib Plus PD-1 Antibodies Shows Promise in NSCLC Patients After Anti-PD-1 Therapy Failure

DNMT Inhibitors Combined with Anti-PD-1 Therapy Show Promise for Refractory NK/T-Cell Lymphoma

Henlius' Serplulimab Makes History as First PD-1 Inhibitor Approved in EU for Small Cell Lung Cancer